4
Changes in Ownership
LISATA THERAPEUTICS, INC. Filed Acc 0001879231-24-000002
EVP, R&D and CMO gave up 5,880 shares (to pay taxes)
- EVP, R&D and CMO acquired 27,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Buck Kristen K · EVP, R&D and CMO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-09 | Grant or award : show line 1 in the form | +27,000 | 59,915 | D | ||
| 2024-01-09 | Shares withheld for taxes : show line 2 in the form | −3,221 | $3.08 | $9,921 | 56,694 | D |
| 2024-01-09 | Shares withheld for taxes : show line 3 in the form | −2,147 | $3.08 | $6,613 | 54,547 | D |
| 2024-01-10 | Shares withheld for taxes : show line 4 in the form | −512 | $3.00 | $1,536 | 54,035 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-09 | Grant or award : show line 5 in the form Stock Option (Right to Buy) | +14,000 | 14,000 | D |
Loading xslF345X05/wk-form4_1705007506.xml…